Medical Care
Global Degenerative Disc Disease Threpeutics Market Research Report 2025
- Sep 09, 25
- ID: 493602
- Pages: 71
- Figures: 74
- Views: 17
This report aims to provide a comprehensive presentation of the global market for Degenerative Disc Disease Threpeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Degenerative Disc Disease Threpeutics.
The Degenerative Disc Disease Threpeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Degenerative Disc Disease Threpeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Degenerative Disc Disease Threpeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AnGes MG Inc
Biopharm GmbH
BioRestorative Therapies Inc
Bone Therapeutics SA
DiscGenics Inc
Osiris Therapeutics Inc
Samumed LLC
TissueGene Inc
U.S. Stem Cell Inc
Yuhan Corp
Segment by Type
ALLOB
AMG-0101
BRTX-100
OTICR-01
Others
Segment by Application
Clinic
Hospital
Homecare
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Degenerative Disc Disease Threpeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Degenerative Disc Disease Threpeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Degenerative Disc Disease Threpeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Degenerative Disc Disease Threpeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AnGes MG Inc
Biopharm GmbH
BioRestorative Therapies Inc
Bone Therapeutics SA
DiscGenics Inc
Osiris Therapeutics Inc
Samumed LLC
TissueGene Inc
U.S. Stem Cell Inc
Yuhan Corp
Segment by Type
ALLOB
AMG-0101
BRTX-100
OTICR-01
Others
Segment by Application
Clinic
Hospital
Homecare
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Degenerative Disc Disease Threpeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ALLOB
1.2.3 AMG-0101
1.2.4 BRTX-100
1.2.5 OTICR-01
1.2.6 Others
1.3 Market by Application
1.3.1 Global Degenerative Disc Disease Threpeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Degenerative Disc Disease Threpeutics Market Perspective (2020-2031)
2.2 Global Degenerative Disc Disease Threpeutics Growth Trends by Region
2.2.1 Global Degenerative Disc Disease Threpeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Degenerative Disc Disease Threpeutics Historic Market Size by Region (2020-2025)
2.2.3 Degenerative Disc Disease Threpeutics Forecasted Market Size by Region (2026-2031)
2.3 Degenerative Disc Disease Threpeutics Market Dynamics
2.3.1 Degenerative Disc Disease Threpeutics Industry Trends
2.3.2 Degenerative Disc Disease Threpeutics Market Drivers
2.3.3 Degenerative Disc Disease Threpeutics Market Challenges
2.3.4 Degenerative Disc Disease Threpeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue
3.1.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue (2020-2025)
3.1.2 Global Degenerative Disc Disease Threpeutics Revenue Market Share by Players (2020-2025)
3.2 Global Degenerative Disc Disease Threpeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Degenerative Disc Disease Threpeutics Revenue
3.4 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio
3.4.1 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Degenerative Disc Disease Threpeutics Revenue in 2024
3.5 Global Key Players of Degenerative Disc Disease Threpeutics Head office and Area Served
3.6 Global Key Players of Degenerative Disc Disease Threpeutics, Product and Application
3.7 Global Key Players of Degenerative Disc Disease Threpeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Degenerative Disc Disease Threpeutics Breakdown Data by Type
4.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Type (2020-2025)
4.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2026-2031)
5 Degenerative Disc Disease Threpeutics Breakdown Data by Application
5.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Application (2020-2025)
5.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Degenerative Disc Disease Threpeutics Market Size (2020-2031)
6.2 North America Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
6.4 North America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Degenerative Disc Disease Threpeutics Market Size (2020-2031)
7.2 Europe Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
7.4 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size (2020-2031)
8.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Degenerative Disc Disease Threpeutics Market Size (2020-2031)
9.2 Latin America Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
9.4 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size (2020-2031)
10.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AnGes MG Inc
11.1.1 AnGes MG Inc Company Details
11.1.2 AnGes MG Inc Business Overview
11.1.3 AnGes MG Inc Degenerative Disc Disease Threpeutics Introduction
11.1.4 AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.1.5 AnGes MG Inc Recent Development
11.2 Biopharm GmbH
11.2.1 Biopharm GmbH Company Details
11.2.2 Biopharm GmbH Business Overview
11.2.3 Biopharm GmbH Degenerative Disc Disease Threpeutics Introduction
11.2.4 Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.2.5 Biopharm GmbH Recent Development
11.3 BioRestorative Therapies Inc
11.3.1 BioRestorative Therapies Inc Company Details
11.3.2 BioRestorative Therapies Inc Business Overview
11.3.3 BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Introduction
11.3.4 BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.3.5 BioRestorative Therapies Inc Recent Development
11.4 Bone Therapeutics SA
11.4.1 Bone Therapeutics SA Company Details
11.4.2 Bone Therapeutics SA Business Overview
11.4.3 Bone Therapeutics SA Degenerative Disc Disease Threpeutics Introduction
11.4.4 Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.4.5 Bone Therapeutics SA Recent Development
11.5 DiscGenics Inc
11.5.1 DiscGenics Inc Company Details
11.5.2 DiscGenics Inc Business Overview
11.5.3 DiscGenics Inc Degenerative Disc Disease Threpeutics Introduction
11.5.4 DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.5.5 DiscGenics Inc Recent Development
11.6 Osiris Therapeutics Inc
11.6.1 Osiris Therapeutics Inc Company Details
11.6.2 Osiris Therapeutics Inc Business Overview
11.6.3 Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Introduction
11.6.4 Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.6.5 Osiris Therapeutics Inc Recent Development
11.7 Samumed LLC
11.7.1 Samumed LLC Company Details
11.7.2 Samumed LLC Business Overview
11.7.3 Samumed LLC Degenerative Disc Disease Threpeutics Introduction
11.7.4 Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.7.5 Samumed LLC Recent Development
11.8 TissueGene Inc
11.8.1 TissueGene Inc Company Details
11.8.2 TissueGene Inc Business Overview
11.8.3 TissueGene Inc Degenerative Disc Disease Threpeutics Introduction
11.8.4 TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.8.5 TissueGene Inc Recent Development
11.9 U.S. Stem Cell Inc
11.9.1 U.S. Stem Cell Inc Company Details
11.9.2 U.S. Stem Cell Inc Business Overview
11.9.3 U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Introduction
11.9.4 U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.9.5 U.S. Stem Cell Inc Recent Development
11.10 Yuhan Corp
11.10.1 Yuhan Corp Company Details
11.10.2 Yuhan Corp Business Overview
11.10.3 Yuhan Corp Degenerative Disc Disease Threpeutics Introduction
11.10.4 Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.10.5 Yuhan Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 ALLOB
1.2.3 AMG-0101
1.2.4 BRTX-100
1.2.5 OTICR-01
1.2.6 Others
1.3 Market by Application
1.3.1 Global Degenerative Disc Disease Threpeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Degenerative Disc Disease Threpeutics Market Perspective (2020-2031)
2.2 Global Degenerative Disc Disease Threpeutics Growth Trends by Region
2.2.1 Global Degenerative Disc Disease Threpeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Degenerative Disc Disease Threpeutics Historic Market Size by Region (2020-2025)
2.2.3 Degenerative Disc Disease Threpeutics Forecasted Market Size by Region (2026-2031)
2.3 Degenerative Disc Disease Threpeutics Market Dynamics
2.3.1 Degenerative Disc Disease Threpeutics Industry Trends
2.3.2 Degenerative Disc Disease Threpeutics Market Drivers
2.3.3 Degenerative Disc Disease Threpeutics Market Challenges
2.3.4 Degenerative Disc Disease Threpeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue
3.1.1 Global Top Degenerative Disc Disease Threpeutics Players by Revenue (2020-2025)
3.1.2 Global Degenerative Disc Disease Threpeutics Revenue Market Share by Players (2020-2025)
3.2 Global Degenerative Disc Disease Threpeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Degenerative Disc Disease Threpeutics Revenue
3.4 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio
3.4.1 Global Degenerative Disc Disease Threpeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Degenerative Disc Disease Threpeutics Revenue in 2024
3.5 Global Key Players of Degenerative Disc Disease Threpeutics Head office and Area Served
3.6 Global Key Players of Degenerative Disc Disease Threpeutics, Product and Application
3.7 Global Key Players of Degenerative Disc Disease Threpeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Degenerative Disc Disease Threpeutics Breakdown Data by Type
4.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Type (2020-2025)
4.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2026-2031)
5 Degenerative Disc Disease Threpeutics Breakdown Data by Application
5.1 Global Degenerative Disc Disease Threpeutics Historic Market Size by Application (2020-2025)
5.2 Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Degenerative Disc Disease Threpeutics Market Size (2020-2031)
6.2 North America Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
6.4 North America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Degenerative Disc Disease Threpeutics Market Size (2020-2031)
7.2 Europe Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
7.4 Europe Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size (2020-2031)
8.2 Asia-Pacific Degenerative Disc Disease Threpeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Degenerative Disc Disease Threpeutics Market Size (2020-2031)
9.2 Latin America Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
9.4 Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size (2020-2031)
10.2 Middle East & Africa Degenerative Disc Disease Threpeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AnGes MG Inc
11.1.1 AnGes MG Inc Company Details
11.1.2 AnGes MG Inc Business Overview
11.1.3 AnGes MG Inc Degenerative Disc Disease Threpeutics Introduction
11.1.4 AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.1.5 AnGes MG Inc Recent Development
11.2 Biopharm GmbH
11.2.1 Biopharm GmbH Company Details
11.2.2 Biopharm GmbH Business Overview
11.2.3 Biopharm GmbH Degenerative Disc Disease Threpeutics Introduction
11.2.4 Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.2.5 Biopharm GmbH Recent Development
11.3 BioRestorative Therapies Inc
11.3.1 BioRestorative Therapies Inc Company Details
11.3.2 BioRestorative Therapies Inc Business Overview
11.3.3 BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Introduction
11.3.4 BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.3.5 BioRestorative Therapies Inc Recent Development
11.4 Bone Therapeutics SA
11.4.1 Bone Therapeutics SA Company Details
11.4.2 Bone Therapeutics SA Business Overview
11.4.3 Bone Therapeutics SA Degenerative Disc Disease Threpeutics Introduction
11.4.4 Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.4.5 Bone Therapeutics SA Recent Development
11.5 DiscGenics Inc
11.5.1 DiscGenics Inc Company Details
11.5.2 DiscGenics Inc Business Overview
11.5.3 DiscGenics Inc Degenerative Disc Disease Threpeutics Introduction
11.5.4 DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.5.5 DiscGenics Inc Recent Development
11.6 Osiris Therapeutics Inc
11.6.1 Osiris Therapeutics Inc Company Details
11.6.2 Osiris Therapeutics Inc Business Overview
11.6.3 Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Introduction
11.6.4 Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.6.5 Osiris Therapeutics Inc Recent Development
11.7 Samumed LLC
11.7.1 Samumed LLC Company Details
11.7.2 Samumed LLC Business Overview
11.7.3 Samumed LLC Degenerative Disc Disease Threpeutics Introduction
11.7.4 Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.7.5 Samumed LLC Recent Development
11.8 TissueGene Inc
11.8.1 TissueGene Inc Company Details
11.8.2 TissueGene Inc Business Overview
11.8.3 TissueGene Inc Degenerative Disc Disease Threpeutics Introduction
11.8.4 TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.8.5 TissueGene Inc Recent Development
11.9 U.S. Stem Cell Inc
11.9.1 U.S. Stem Cell Inc Company Details
11.9.2 U.S. Stem Cell Inc Business Overview
11.9.3 U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Introduction
11.9.4 U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.9.5 U.S. Stem Cell Inc Recent Development
11.10 Yuhan Corp
11.10.1 Yuhan Corp Company Details
11.10.2 Yuhan Corp Business Overview
11.10.3 Yuhan Corp Degenerative Disc Disease Threpeutics Introduction
11.10.4 Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025)
11.10.5 Yuhan Corp Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ALLOB
Table 3. Key Players of AMG-0101
Table 4. Key Players of BRTX-100
Table 5. Key Players of OTICR-01
Table 6. Key Players of Others
Table 7. Global Degenerative Disc Disease Threpeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Degenerative Disc Disease Threpeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Degenerative Disc Disease Threpeutics Market Share by Region (2020-2025)
Table 11. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Degenerative Disc Disease Threpeutics Market Share by Region (2026-2031)
Table 13. Degenerative Disc Disease Threpeutics Market Trends
Table 14. Degenerative Disc Disease Threpeutics Market Drivers
Table 15. Degenerative Disc Disease Threpeutics Market Challenges
Table 16. Degenerative Disc Disease Threpeutics Market Restraints
Table 17. Global Degenerative Disc Disease Threpeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Degenerative Disc Disease Threpeutics Market Share by Players (2020-2025)
Table 19. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2024)
Table 20. Ranking of Global Top Degenerative Disc Disease Threpeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Degenerative Disc Disease Threpeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Degenerative Disc Disease Threpeutics, Headquarters and Area Served
Table 23. Global Key Players of Degenerative Disc Disease Threpeutics, Product and Application
Table 24. Global Key Players of Degenerative Disc Disease Threpeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Degenerative Disc Disease Threpeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Degenerative Disc Disease Threpeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. AnGes MG Inc Company Details
Table 50. AnGes MG Inc Business Overview
Table 51. AnGes MG Inc Degenerative Disc Disease Threpeutics Product
Table 52. AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 53. AnGes MG Inc Recent Development
Table 54. Biopharm GmbH Company Details
Table 55. Biopharm GmbH Business Overview
Table 56. Biopharm GmbH Degenerative Disc Disease Threpeutics Product
Table 57. Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 58. Biopharm GmbH Recent Development
Table 59. BioRestorative Therapies Inc Company Details
Table 60. BioRestorative Therapies Inc Business Overview
Table 61. BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Product
Table 62. BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 63. BioRestorative Therapies Inc Recent Development
Table 64. Bone Therapeutics SA Company Details
Table 65. Bone Therapeutics SA Business Overview
Table 66. Bone Therapeutics SA Degenerative Disc Disease Threpeutics Product
Table 67. Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 68. Bone Therapeutics SA Recent Development
Table 69. DiscGenics Inc Company Details
Table 70. DiscGenics Inc Business Overview
Table 71. DiscGenics Inc Degenerative Disc Disease Threpeutics Product
Table 72. DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 73. DiscGenics Inc Recent Development
Table 74. Osiris Therapeutics Inc Company Details
Table 75. Osiris Therapeutics Inc Business Overview
Table 76. Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Product
Table 77. Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 78. Osiris Therapeutics Inc Recent Development
Table 79. Samumed LLC Company Details
Table 80. Samumed LLC Business Overview
Table 81. Samumed LLC Degenerative Disc Disease Threpeutics Product
Table 82. Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 83. Samumed LLC Recent Development
Table 84. TissueGene Inc Company Details
Table 85. TissueGene Inc Business Overview
Table 86. TissueGene Inc Degenerative Disc Disease Threpeutics Product
Table 87. TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 88. TissueGene Inc Recent Development
Table 89. U.S. Stem Cell Inc Company Details
Table 90. U.S. Stem Cell Inc Business Overview
Table 91. U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Product
Table 92. U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 93. U.S. Stem Cell Inc Recent Development
Table 94. Yuhan Corp Company Details
Table 95. Yuhan Corp Business Overview
Table 96. Yuhan Corp Degenerative Disc Disease Threpeutics Product
Table 97. Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 98. Yuhan Corp Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Degenerative Disc Disease Threpeutics Picture
Figure 2. Global Degenerative Disc Disease Threpeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Degenerative Disc Disease Threpeutics Market Share by Type: 2024 VS 2031
Figure 4. ALLOB Features
Figure 5. AMG-0101 Features
Figure 6. BRTX-100 Features
Figure 7. OTICR-01 Features
Figure 8. Others Features
Figure 9. Global Degenerative Disc Disease Threpeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Degenerative Disc Disease Threpeutics Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Homecare Case Studies
Figure 14. Degenerative Disc Disease Threpeutics Report Years Considered
Figure 15. Global Degenerative Disc Disease Threpeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Degenerative Disc Disease Threpeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Degenerative Disc Disease Threpeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Degenerative Disc Disease Threpeutics Market Share by Players in 2024
Figure 19. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Degenerative Disc Disease Threpeutics Revenue in 2024
Figure 21. North America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 23. United States Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 27. Germany Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Degenerative Disc Disease Threpeutics Market Share by Region (2020-2031)
Figure 35. China Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 43. Mexico Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 47. Turkey Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AnGes MG Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 51. Biopharm GmbH Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 52. BioRestorative Therapies Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 53. Bone Therapeutics SA Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 54. DiscGenics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 55. Osiris Therapeutics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 56. Samumed LLC Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 57. TissueGene Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 58. U.S. Stem Cell Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 59. Yuhan Corp Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Degenerative Disc Disease Threpeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of ALLOB
Table 3. Key Players of AMG-0101
Table 4. Key Players of BRTX-100
Table 5. Key Players of OTICR-01
Table 6. Key Players of Others
Table 7. Global Degenerative Disc Disease Threpeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Degenerative Disc Disease Threpeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Degenerative Disc Disease Threpeutics Market Share by Region (2020-2025)
Table 11. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Degenerative Disc Disease Threpeutics Market Share by Region (2026-2031)
Table 13. Degenerative Disc Disease Threpeutics Market Trends
Table 14. Degenerative Disc Disease Threpeutics Market Drivers
Table 15. Degenerative Disc Disease Threpeutics Market Challenges
Table 16. Degenerative Disc Disease Threpeutics Market Restraints
Table 17. Global Degenerative Disc Disease Threpeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Degenerative Disc Disease Threpeutics Market Share by Players (2020-2025)
Table 19. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2024)
Table 20. Ranking of Global Top Degenerative Disc Disease Threpeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Degenerative Disc Disease Threpeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Degenerative Disc Disease Threpeutics, Headquarters and Area Served
Table 23. Global Key Players of Degenerative Disc Disease Threpeutics, Product and Application
Table 24. Global Key Players of Degenerative Disc Disease Threpeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Degenerative Disc Disease Threpeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Degenerative Disc Disease Threpeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Degenerative Disc Disease Threpeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Degenerative Disc Disease Threpeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. AnGes MG Inc Company Details
Table 50. AnGes MG Inc Business Overview
Table 51. AnGes MG Inc Degenerative Disc Disease Threpeutics Product
Table 52. AnGes MG Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 53. AnGes MG Inc Recent Development
Table 54. Biopharm GmbH Company Details
Table 55. Biopharm GmbH Business Overview
Table 56. Biopharm GmbH Degenerative Disc Disease Threpeutics Product
Table 57. Biopharm GmbH Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 58. Biopharm GmbH Recent Development
Table 59. BioRestorative Therapies Inc Company Details
Table 60. BioRestorative Therapies Inc Business Overview
Table 61. BioRestorative Therapies Inc Degenerative Disc Disease Threpeutics Product
Table 62. BioRestorative Therapies Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 63. BioRestorative Therapies Inc Recent Development
Table 64. Bone Therapeutics SA Company Details
Table 65. Bone Therapeutics SA Business Overview
Table 66. Bone Therapeutics SA Degenerative Disc Disease Threpeutics Product
Table 67. Bone Therapeutics SA Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 68. Bone Therapeutics SA Recent Development
Table 69. DiscGenics Inc Company Details
Table 70. DiscGenics Inc Business Overview
Table 71. DiscGenics Inc Degenerative Disc Disease Threpeutics Product
Table 72. DiscGenics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 73. DiscGenics Inc Recent Development
Table 74. Osiris Therapeutics Inc Company Details
Table 75. Osiris Therapeutics Inc Business Overview
Table 76. Osiris Therapeutics Inc Degenerative Disc Disease Threpeutics Product
Table 77. Osiris Therapeutics Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 78. Osiris Therapeutics Inc Recent Development
Table 79. Samumed LLC Company Details
Table 80. Samumed LLC Business Overview
Table 81. Samumed LLC Degenerative Disc Disease Threpeutics Product
Table 82. Samumed LLC Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 83. Samumed LLC Recent Development
Table 84. TissueGene Inc Company Details
Table 85. TissueGene Inc Business Overview
Table 86. TissueGene Inc Degenerative Disc Disease Threpeutics Product
Table 87. TissueGene Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 88. TissueGene Inc Recent Development
Table 89. U.S. Stem Cell Inc Company Details
Table 90. U.S. Stem Cell Inc Business Overview
Table 91. U.S. Stem Cell Inc Degenerative Disc Disease Threpeutics Product
Table 92. U.S. Stem Cell Inc Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 93. U.S. Stem Cell Inc Recent Development
Table 94. Yuhan Corp Company Details
Table 95. Yuhan Corp Business Overview
Table 96. Yuhan Corp Degenerative Disc Disease Threpeutics Product
Table 97. Yuhan Corp Revenue in Degenerative Disc Disease Threpeutics Business (2020-2025) & (US$ Million)
Table 98. Yuhan Corp Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
Table 102. Authors List of This Report
List of Figures
Figure 1. Degenerative Disc Disease Threpeutics Picture
Figure 2. Global Degenerative Disc Disease Threpeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Degenerative Disc Disease Threpeutics Market Share by Type: 2024 VS 2031
Figure 4. ALLOB Features
Figure 5. AMG-0101 Features
Figure 6. BRTX-100 Features
Figure 7. OTICR-01 Features
Figure 8. Others Features
Figure 9. Global Degenerative Disc Disease Threpeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Degenerative Disc Disease Threpeutics Market Share by Application: 2024 VS 2031
Figure 11. Clinic Case Studies
Figure 12. Hospital Case Studies
Figure 13. Homecare Case Studies
Figure 14. Degenerative Disc Disease Threpeutics Report Years Considered
Figure 15. Global Degenerative Disc Disease Threpeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Degenerative Disc Disease Threpeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Degenerative Disc Disease Threpeutics Market Share by Region: 2024 VS 2031
Figure 18. Global Degenerative Disc Disease Threpeutics Market Share by Players in 2024
Figure 19. Global Top Degenerative Disc Disease Threpeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Degenerative Disc Disease Threpeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Degenerative Disc Disease Threpeutics Revenue in 2024
Figure 21. North America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 23. United States Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 27. Germany Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Degenerative Disc Disease Threpeutics Market Share by Region (2020-2031)
Figure 35. China Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 43. Mexico Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Degenerative Disc Disease Threpeutics Market Share by Country (2020-2031)
Figure 47. Turkey Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Degenerative Disc Disease Threpeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. AnGes MG Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 51. Biopharm GmbH Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 52. BioRestorative Therapies Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 53. Bone Therapeutics SA Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 54. DiscGenics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 55. Osiris Therapeutics Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 56. Samumed LLC Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 57. TissueGene Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 58. U.S. Stem Cell Inc Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 59. Yuhan Corp Revenue Growth Rate in Degenerative Disc Disease Threpeutics Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Images Type AIGC Market Research Report 2025
Dec 02, 25
Global Screen Reading Tool for the Blind Market Research Report 2025
Dec 02, 25
Global Full Stack Perception Software Market Research Report 2025
Dec 02, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232